CRISPR-BasedGeneDrivesforVectorControl

Why It Matters

Mosquito-borne diseases like malaria and dengue affect hundreds of millions annually, causing over 600,000 deaths, while agricultural pests cause billions in crop losses. When mainstream, gene drives could eliminate specific pest populations or render them harmless, allowing for dramatically reduced disease burden and pesticide use. Farmers would see higher yields and lower costs, while pharmaceutical companies might lose some infectious disease drug markets; environmental groups are divided on the risks of ecological disruption. The main barriers are public acceptance, stringent regulatory frameworks due to potential ecological impacts, and the difficulty of predicting long-term evolutionary responses. A realistic timeline for limited, controlled field deployment could be 5-10 years, with widespread adoption taking 15-20 years. The US (USDA, DARPA), UK, and Australia are racing to develop these, often collaborating on vector control. A second-order consequence is that the removal of a pest species could create an ecological vacuum, potentially allowing other, perhaps more resilient or harmful, species to fill its niche.